Advanced search
1 file | 367.22 KB

Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome

Author
Organization
Abstract
Osteogenesis imperfecta (OI) and Marfan syndrome (MFS) are common Mendelian disorders. Both conditions are usually diagnosed clinically, as genetic testing is expensive due to the size and number of potentially causative genes and mutations. However, genetic testing may benefit patients, at-risk family members and individuals with borderline phenotypes, as well as improving genetic counseling and allowing critical differential diagnoses. We assessed whether whole exome sequencing (WES) is a sensitive method for mutation detection in OI and MFS. WES was performed on genomic DNA from 13 participants with OI and 10 participants with MFS who had known mutations, with exome capture followed by massive parallel sequencing of multiplexed samples. Single nucleotide polymorphisms (SNPs) and small indels were called using Genome Analysis Toolkit (GATK) and annotated with ANNOVAR. CREST, exomeCopy and exomeDepth were used for large deletion detection. Results were compared with the previous data. Specificity was calculated by screening WES data from a control population of 487 individuals for mutations in COL1A1, COL1A2 and FBN1. The target capture of five exome capture platforms was compared. All 13 mutations in the OI cohort and 9/10 in the MFS cohort were detected (sensitivity=95.6%) including non-synonymous SNPs, small indels (<10 bp), and a large UTR5/exon 1 deletion. One mutation was not detected by GATK due to strand bias. Specificity was 99.5%. Capture platforms and analysis programs differed considerably in their ability to detect mutations. Consumable costs for WES were low. WES is an efficient, sensitive, specific and cost-effective method for mutation detection in patients with OI and MFS. Careful selection of platform and analysis programs is necessary to maximize success.

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 367.22 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Mclnerney-Leo, Aideen M, Mhairi S Marshall, Brooke Gardiner, Paul Coucke, Lut Van Laer, Bart L Loeys, Kim M Summers, et al. 2013. “Whole Exome Sequencing Is an Efficient, Sensitive and Specific Method of Mutation Detection in Osteogenesis Imperfecta and Marfan Syndrome.” Bonekey Reports 2.
APA
Mclnerney-Leo, A. M., Marshall, M. S., Gardiner, B., Coucke, P., Van Laer, L., Loeys, B. L., Summers, K. M., et al. (2013). Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome. BONEKEY REPORTS, 2.
Vancouver
1.
Mclnerney-Leo AM, Marshall MS, Gardiner B, Coucke P, Van Laer L, Loeys BL, et al. Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome. BONEKEY REPORTS. 2013;2.
MLA
Mclnerney-Leo, Aideen M, Mhairi S Marshall, Brooke Gardiner, et al. “Whole Exome Sequencing Is an Efficient, Sensitive and Specific Method of Mutation Detection in Osteogenesis Imperfecta and Marfan Syndrome.” BONEKEY REPORTS 2 (2013): n. pag. Print.
@article{5848079,
  abstract     = {Osteogenesis imperfecta (OI) and Marfan syndrome (MFS) are common Mendelian disorders. Both conditions are usually diagnosed clinically, as genetic testing is expensive due to the size and number of potentially causative genes and mutations. However, genetic testing may benefit patients, at-risk family members and individuals with borderline phenotypes, as well as improving genetic counseling and allowing critical differential diagnoses. We assessed whether whole exome sequencing (WES) is a sensitive method for mutation detection in OI and MFS. WES was performed on genomic DNA from 13 participants with OI and 10 participants with MFS who had known mutations, with exome capture followed by massive parallel sequencing of multiplexed samples. Single nucleotide polymorphisms (SNPs) and small indels were called using Genome Analysis Toolkit (GATK) and annotated with ANNOVAR. CREST, exomeCopy and exomeDepth were used for large deletion detection. Results were compared with the previous data. Specificity was calculated by screening WES data from a control population of 487 individuals for mutations in COL1A1, COL1A2 and FBN1. The target capture of five exome capture platforms was compared. All 13 mutations in the OI cohort and 9/10 in the MFS cohort were detected (sensitivity=95.6%) including non-synonymous SNPs, small indels (<10 bp), and a large UTR5/exon 1 deletion. One mutation was not detected by GATK due to strand bias. Specificity was 99.5%. Capture platforms and analysis programs differed considerably in their ability to detect mutations. Consumable costs for WES were low. WES is an efficient, sensitive, specific and cost-effective method for mutation detection in patients with OI and MFS. Careful selection of platform and analysis programs is necessary to maximize success.},
  articleno    = {456},
  author       = {Mclnerney-Leo, Aideen M and Marshall, Mhairi S and Gardiner, Brooke and Coucke, Paul and Van Laer, Lut and Loeys, Bart L and Summers, Kim M and Symoens, Sofie and West, Jennifer A and West, Malcolm J and Wordsworth, B Paul and Zankl, Andreas and Leo, Paul J and Brown, Matthew A and Duncan, Emma L},
  issn         = {2047-6396},
  journal      = {BONEKEY REPORTS},
  language     = {eng},
  pages        = {9},
  title        = {Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndrome},
  url          = {http://dx.doi.org/10.1038/bonekey.2013.190},
  volume       = {2},
  year         = {2013},
}

Altmetric
View in Altmetric